{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:29:00Z","timestamp":1786422540682,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008702","name":"Kagoshima University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008702","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07214-9","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:44:22Z","timestamp":1784101462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical factors associated with retreatment and early coronary outcomes in Kawasaki disease in children aged < 6 months: a single-center cohort study"],"prefix":"10.1007","volume":"185","author":[{"given":"Kensuke","family":"Horinouchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0656-570X","authenticated-orcid":false,"given":"Kentaro","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Iwaizako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Shimozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9968-2248","authenticated-orcid":false,"given":"Junpei","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6873-042X","authenticated-orcid":false,"given":"Daisuke","family":"Hazeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshirou","family":"Fukushige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7381-410X","authenticated-orcid":false,"given":"Yuichi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"7214_CR1","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927-999. https:\/\/doi.org\/10.1161\/CIR.0000000000000484","journal-title":"Circulation"},{"key":"7214_CR2","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1161\/CIR.0000000000001295","volume":"150","author":"PN Jone","year":"2024","unstructured":"Jone PN, Tremoulet A, Choueiter N, Dominguez SR, Harahsheh AS, Mitani Y et al (2024) Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association. Circulation 150:e481-500. https:\/\/doi.org\/10.1161\/CIR.0000000000001295. (Erratum in: (2025). Circulation 151:e863. 10.1161\/CIR.0000000000001324)","journal-title":"Circulation"},{"key":"7214_CR3","first-page":"41","volume":"5","author":"M Miura","year":"2021","unstructured":"Miura M, Ayusawa M, Fukazawa R, Hamada H, Ikeda S, Ito S et al (2021) Guidelines for medical treatment of acute Kawasaki disease (2020 revised version). JPCCS 5:41\u201373","journal-title":"JPCCS"},{"key":"7214_CR4","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","volume":"84","author":"R Fukazawa","year":"2020","unstructured":"Fukazawa R, Kobayashi J, Ayusawa M, Hamada H, Miura M, Mitani Y et al (2020) JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease. Circ J 84:1348\u20131407. https:\/\/doi.org\/10.1253\/circj.CJ-19-1094","journal-title":"Circ J"},{"key":"7214_CR5","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/ped.14326","volume":"62","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Ayusawa M, Suzuki H, Abe J, Ito S, Kato T et al (2020) Revision of diagnostic guidelines for Kawasaki disease (6th revised edition). Pediatr Int 62:1135\u20131138. https:\/\/doi.org\/10.1111\/ped.14326","journal-title":"Pediatr Int"},{"key":"7214_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2020.05.034","volume":"225","author":"R Ae","year":"2020","unstructured":"Ae R, Makino N, Kosami K, Kuwabara M, Matsubara Y, Nakamura Y (2020) Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017\u20132018. J Pediatr 225:23-29.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2020.05.034","journal-title":"J Pediatr"},{"key":"7214_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpeds.2017.03.025","volume":"185","author":"AP Salgado","year":"2017","unstructured":"Salgado AP, Ashouri N, Berry EK, Sun X, Jain S, Burns JC, Tremoulet AH (2017) High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease. J Pediatr 185:112-116.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2017.03.025","journal-title":"J Pediatr"},{"key":"7214_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fped.2020.00384","volume":"8","author":"E Moreno","year":"2020","unstructured":"Moreno E, Garcia SD, Bainto E, Salgado AP, Parish A, Rosellini BD et al (2020) Presentation and outcomes of Kawasaki disease in Latin American infants younger than 6 months of age: a multinational multicenter study of the REKAMLATINA network. Front Pediatr 8:384. https:\/\/doi.org\/10.3389\/fped.2020.00384","journal-title":"Front Pediatr"},{"key":"7214_CR9","doi-asserted-by":"publisher","first-page":"e005378","DOI":"10.1161\/JAHA.116.005378","volume":"6","author":"MBF Son","year":"2017","unstructured":"Son MBF, Gauvreau K, Kim S, Tang A, Dedeoglu F, Fulton DR et al (2017) Predicting coronary artery aneurysms in Kawasaki disease at a North American center: an assessment of baseline z scores. J Am Heart Assoc 6:e005378. https:\/\/doi.org\/10.1161\/JAHA.116.005378","journal-title":"J Am Heart Assoc"},{"key":"7214_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.4070\/kcj.2016.46.4.550","volume":"46","author":"YM Yoon","year":"2016","unstructured":"Yoon YM, Yun HW, Kim SH (2016) Clinical characteristics of Kawasaki disease in infants younger than six months: a single-center study. Korean Circ J 46:550\u2013555. https:\/\/doi.org\/10.4070\/kcj.2016.46.4.550","journal-title":"Korean Circ J"},{"key":"7214_CR11","doi-asserted-by":"publisher","first-page":"e1434","DOI":"10.1542\/peds.2007-0815","volume":"120","author":"LL Minich","year":"2007","unstructured":"Minich LL, Sleeper LA, Atz AM, McCrindle BW, Lu M, Colan SD et al (2007) Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics 120:e1434\u2013e1440. https:\/\/doi.org\/10.1542\/peds.2007-0815","journal-title":"Pediatrics"},{"key":"7214_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/ped.14242","volume":"62","author":"Y Nomura","year":"2020","unstructured":"Nomura Y, Yashiro M, Masuda K, Nakamura Y (2020) Treatment change and coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int 62:779\u2013784. https:\/\/doi.org\/10.1111\/ped.14242","journal-title":"Pediatr Int"},{"key":"7214_CR13","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1253\/circj.CJ-66-0096","volume":"78","author":"JCS Joint Working Group","year":"2014","unstructured":"JCS Joint Working Group (2014) Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version Circ J 78:2521\u20132562. https:\/\/doi.org\/10.1253\/circj.CJ-66-0096","journal-title":"Digest version Circ J"},{"key":"7214_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1442-200x.2005.02033.x","volume":"47","author":"M Ayusawa","year":"2005","unstructured":"Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N et al (2005) Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 47:232\u2013234. https:\/\/doi.org\/10.1111\/j.1442-200x.2005.02033.x","journal-title":"Pediatr Int"},{"key":"7214_CR15","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","volume":"379","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H et al (2012) Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 379:1613\u20131620. https:\/\/doi.org\/10.1016\/S0140-6736(11)61930-2","journal-title":"Lancet"},{"key":"7214_CR16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.echo.2016.03.017","volume":"29","author":"T Kobayashi","year":"2016","unstructured":"Kobayashi T, Fuse S, Sakamoto N, Mikami M, Ogawa S, Hamaoka K et al (2016) A new Z score curve of the coronary arterial internal diameter using the lambda-mu-sigma method in a pediatric population. J Am Soc Echocardiogr 29:794-801.e29. https:\/\/doi.org\/10.1016\/j.echo.2016.03.017","journal-title":"J Am Soc Echocardiogr"},{"key":"7214_CR17","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1038\/s41598-020-59972-7","volume":"10","author":"M Piram","year":"2020","unstructured":"Piram M, Darce Bello M, Tellier S, Di Filippo S, Boralevi F, Madhi F et al (2020) Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease. Sci Rep 10:3125. https:\/\/doi.org\/10.1038\/s41598-020-59972-7","journal-title":"Sci Rep"},{"key":"7214_CR18","doi-asserted-by":"publisher","first-page":"100481","DOI":"10.1016\/j.lanepe.2022.100481","volume":"22","author":"N Ouldali","year":"2022","unstructured":"Ouldali N, Dellepiane RM, Torreggiani S, Mauri L, Beaujour G, Beyler C et al (2022) Development of a score for early identification of children with Kawasaki disease requiring second-line treatment in multi-ethnic populations in Europe: a multicentre retrospective cohort study. Lancet Reg Health Eur 22:100481. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100481","journal-title":"Lancet Reg Health Eur"},{"key":"7214_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4070\/kcj.2016.46.4.542","volume":"46","author":"BY Kim","year":"2016","unstructured":"Kim BY, Kim D, Kim YH, Ryoo E, Sun YH, Jeon IS et al (2016) Non-responders to intravenous immunoglobulin and coronary artery dilatation in Kawasaki disease: predictive parameters in Korean children. Korean Circ J 46:542\u2013549. https:\/\/doi.org\/10.4070\/kcj.2016.46.4.542","journal-title":"Korean Circ J"},{"key":"7214_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.4070\/kcj.2014.44.6.415","volume":"44","author":"SM Lee","year":"2014","unstructured":"Lee SM, Lee JB, Go YB, Song HY, Lee BJ, Kwak JH (2014) Prediction of resistance to standard intravenous immunoglobulin therapy in Kawasaki disease. Korean Circ J 44:415\u2013422. https:\/\/doi.org\/10.4070\/kcj.2014.44.6.415","journal-title":"Korean Circ J"},{"key":"7214_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fped.2019.00081","volume":"7","author":"Y Chen","year":"2019","unstructured":"Chen Y, Hua Y, Zhang C, Chen S, Zhang Q, Liao Y et al (2019) Neutrophil-to-lymphocyte ratio predicts intravenous immunoglobulin-resistance in infants under 12-months old with Kawasaki disease. Front Pediatr 7:81. https:\/\/doi.org\/10.3389\/fped.2019.00081","journal-title":"Front Pediatr"},{"key":"7214_CR22","doi-asserted-by":"publisher","first-page":"e0176957","DOI":"10.1371\/journal.pone.0176957","volume":"12","author":"S Takeshita","year":"2017","unstructured":"Takeshita S, Kanai T, Kawamura Y, Yoshida Y, Nonoyama S (2017) A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (IVIG)-resistance in Kawasaki disease. PLoS ONE 12:e0176957. https:\/\/doi.org\/10.1371\/journal.pone.0176957","journal-title":"PLoS ONE"},{"key":"7214_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpeds.2016.07.035","volume":"178","author":"Y Kawamura","year":"2016","unstructured":"Kawamura Y, Takeshita S, Kanai T, Yoshida Y, Nonoyama S (2016) The combined usefulness of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting intravenous immunoglobulin resistance with Kawasaki disease. J Pediatr 178:281-284.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.07.035","journal-title":"J Pediatr"},{"key":"7214_CR24","doi-asserted-by":"publisher","first-page":"969502","DOI":"10.3389\/fped.2022.969502","volume":"10","author":"C Liu","year":"2022","unstructured":"Liu C, Wu J (2022) Value of blood inflammatory markers for predicting intravenous immunoglobulin resistance in Kawasaki disease: a systematic review and meta-analysis. Front Pediatr 10:969502. https:\/\/doi.org\/10.3389\/fped.2022.969502","journal-title":"Front Pediatr"},{"key":"7214_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/ped.13512","volume":"60","author":"Y Shiozawa","year":"2018","unstructured":"Shiozawa Y, Inuzuka R, Shindo T, Mafune R, Hayashi T, Hirata Y et al (2018) Effect of i.v. immunoglobulin in the first 4 days of illness in Kawasaki disease. Pediatr Int 60:334\u2013341. https:\/\/doi.org\/10.1111\/ped.13512","journal-title":"Pediatr Int"},{"key":"7214_CR26","doi-asserted-by":"publisher","first-page":"593435","DOI":"10.3389\/fped.2020.593435","volume":"8","author":"F Yan","year":"2020","unstructured":"Yan F, Zhang H, Xiong R, Cheng X, Chen Y, Zhang F (2020) Effect of early intravenous immunoglobulin therapy in Kawasaki disease: a systematic review and meta-analysis. Front Pediatr 8:593435. https:\/\/doi.org\/10.3389\/fped.2020.593435","journal-title":"Front Pediatr"},{"key":"7214_CR27","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","volume":"158","author":"LA Sleeper","year":"2011","unstructured":"Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD et al (2011) Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr 158:831-835.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2010.10.031","journal-title":"J Pediatr"},{"key":"7214_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1161\/01.CIR.0000079166.93475.5F","volume":"108","author":"M Terai","year":"2003","unstructured":"Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y (2003) Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 108:325\u2013330. https:\/\/doi.org\/10.1161\/01.CIR.0000079166.93475.5F","journal-title":"Circulation"},{"key":"7214_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12887-017-0895-8","volume":"17","author":"MY Liu","year":"2017","unstructured":"Liu MY, Liu HM, Wu CH, Chang CH, Huang GJ, Chen CA et al (2017) Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease. BMC Pediatr 17:139. https:\/\/doi.org\/10.1186\/s12887-017-0895-8","journal-title":"BMC Pediatr"},{"issue":"Suppl 1","key":"7214_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2249.2011.04361.x","volume":"164","author":"K Takahashi","year":"2011","unstructured":"Takahashi K, Oharaseki T, Yokouchi Y (2011) Pathogenesis of Kawasaki disease. Clin Exp Immunol 164(Suppl 1):20\u201322. https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04361.x","journal-title":"Clin Exp Immunol"},{"key":"7214_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/1756-185X.13207","volume":"21","author":"K Takahashi","year":"2018","unstructured":"Takahashi K, Oharaseki T, Yokouchi Y (2018) Histopathological aspects of cardiovascular lesions in Kawasaki disease. Int J Rheum Dis 21:31\u201335. https:\/\/doi.org\/10.1111\/1756-185X.13207","journal-title":"Int J Rheum Dis"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07214-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07214-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07214-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:49:51Z","timestamp":1786420191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07214-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7214"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07214-9","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Kagoshima City Hospital (Approval No. 2024\u201303, April 17, 2024).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Because of the retrospective design and use of de-identified data, the Institutional Review Board of Kagoshima City Hospital waived the requirement for individual informed consent. In line with national ethical guidelines, study information (including the purpose of data use and anonymization procedures) was publicly disclosed on the Kagoshima City Hospital website (\n                      \n                      ) and within the hospital, and patients\/parents or legal guardians were provided an opportunity to opt out; individuals who declined were excluded from the analysis.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"578"}}